The FDA released its Post‑Outbreak Response Activities after a baby botulism outbreak tied to powdered infant formula. Investigators found no clear entry point for the bacteria, leaving the chain of contamination unresolved. Legal counsel Bill Marler criticized the report as “a little underwhelming to put it mildly.”

ByHeart, one of three companies under scrutiny, said the FDA found no deficiencies in its facilities. Organic West Milk’s owner Bill Van Ryn denied proof of contamination, while Dairy Farmers of America blamed Organic West for meeting all required tests. The blame game exposes gaps in ingredient verification for infant formula.

Marler wants deeper FDA analysis and clearer guidance. He argues the responsibility lies with ByHeart to source, verify, and test ingredients before packaging. This is not the first infant botulism case linked to formula, underscoring systemic weaknesses in the industry’s safety protocols.

ByHeart is collaborating with a lab to develop more sensitive testing for C. botulinum and plans to resume production. Consumers face uncertainty as the FDA offers no definitive prevention steps. The outbreak highlights the urgent need for stricter oversight of powdered infant formula manufacturing.